May 10 (Reuters) - Novavax Inc said on Monday its combined flu and COVID-19 vaccine produced functional antibodies against influenza and the coronavirus in a preclinical study. (https://refini.tv/3bg25TM) (Reporting by Mrinalika Roy in Bengaluru; Editing by Amy Caren Daniel)